These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 20420501

  • 1. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, Harrison C, Bayley K, Watson M, Richmond P.
    Clin Infect Dis; 2010 Jun 01; 50(11):1477-86. PubMed ID: 20420501
    [Abstract] [Full Text] [Related]

  • 2. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR, D'Onise K, Holland RA, Raupach JC, Koehler AP.
    Vaccine; 2012 Mar 09; 30(12):2206-11. PubMed ID: 22273663
    [Abstract] [Full Text] [Related]

  • 3. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.
    Clin Infect Dis; 2010 May 01; 50(9):1238-46. PubMed ID: 20367225
    [Abstract] [Full Text] [Related]

  • 4. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.
    Clin Infect Dis; 2009 Jul 15; 49(2):205-12. PubMed ID: 19508165
    [Abstract] [Full Text] [Related]

  • 5. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
    Guevara M, Barricarte A, Gil-Setas A, García-Irure JJ, Beristain X, Torroba L, Petit A, Polo Vigas ME, Aguinaga A, Castilla J.
    Clin Microbiol Infect; 2009 Nov 15; 15(11):1013-9. PubMed ID: 19673968
    [Abstract] [Full Text] [Related]

  • 6. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 7. Invasive pneumococcal disease in Australia, 2006.
    Roche PW, Krause V, Cook H, Barralet J, Coleman D, Sweeny A, Fielding J, Giele C, Gilmour R, Holland R, Kampen R, Enhanced Invasive Pneumococcal Disease Surveillance Working Group, Brown M, Gilbert L, Hogg G, Murphy D, Pneumococcal Working Party of the Communicable Diseases Network Australia.
    Commun Dis Intell Q Rep; 2008 Mar 15; 32(1):18-30. PubMed ID: 18522302
    [Abstract] [Full Text] [Related]

  • 8. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr 15; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 9. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
    Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, Moore MR, CDC Emerging Infections Program Network.
    Clin Infect Dis; 2011 Jul 15; 53(2):137-43. PubMed ID: 21690620
    [Abstract] [Full Text] [Related]

  • 10. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C, Moore H, Bayley K, Harrison C, Murphy D, Rooney K, Keil AD, Lehmann D.
    Vaccine; 2007 Mar 22; 25(13):2379-84. PubMed ID: 17064825
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
    Jayasinghe S, Chiu C, Menzies R, Lehmann D, Cook H, Giele C, Krause V, McIntyre P.
    Vaccine; 2015 Nov 27; 33(48):6666-74. PubMed ID: 26519550
    [Abstract] [Full Text] [Related]

  • 12. Invasive pneumococcal disease in Australia 2007 and 2008.
    Barry C, Krause VL, Cook HM, Menzies RI.
    Commun Dis Intell Q Rep; 2012 Jun 30; 36(2):E151-65. PubMed ID: 23186214
    [Abstract] [Full Text] [Related]

  • 13. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R.
    Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247
    [Abstract] [Full Text] [Related]

  • 14. Invasive pneumococcal disease in Australia, 2004.
    Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, Fielding JE, Holland R, Giele C, Gilmour R, Kampen R, Brown M, Gilbert L, Hogg G, Murphy D, Pneumococcal Working Party of the Communicable Diseases Network Australia.
    Commun Dis Intell Q Rep; 2006 Jan 15; 30(1):80-92. PubMed ID: 16637236
    [Abstract] [Full Text] [Related]

  • 15. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep 15; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 16. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.
    Enferm Infecc Microbiol Clin; 2009 Jan 15; 27(1):14-21. PubMed ID: 19217998
    [Abstract] [Full Text] [Related]

  • 17. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.
    Salleras L, Domínguez A, Ciruela P, Izquierdo C, Navas E, Torner N, Borras E.
    Clin Microbiol Infect; 2009 Nov 15; 15(11):997-1001. PubMed ID: 19689466
    [Abstract] [Full Text] [Related]

  • 18. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, McIntyre P, Menzies R.
    Commun Dis Intell Q Rep; 2013 Dec 31; 37 Suppl():S1-95. PubMed ID: 24410428
    [Abstract] [Full Text] [Related]

  • 19. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J, Benes C, Kriz P.
    Epidemiol Infect; 2009 Apr 31; 137(4):562-9. PubMed ID: 18796171
    [Abstract] [Full Text] [Related]

  • 20. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L, Danish Pneumococcal Surveillance Collaboration Group 2009-2010.
    Vaccine; 2012 Jun 06; 30(26):3944-50. PubMed ID: 22504662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.